Clinical Trials Directory

Trials / Unknown

UnknownNCT04091516

Feasibility & Implementation of a Plant-Based Weight-Loss Program in an Office-Based Setting

The Feasibility, Implementation and Efficacy of a Plant-Based Weight-Loss Program in a Practice-Based Setting

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Physicians Committee for Responsible Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This prospective study aims to assess the feasibility and implementation of a plant-based, weight-loss program in an office setting. The study will also assess changes in body weight, blood pressure, plasma lipids, glycated hemoglobin, and body composition with a 12-week, plant-based, weight-loss program. These health benefits may illustrate feasibility to physicians and healthcare professionals elsewhere.

Detailed description

This will be a prospective interventional study to evaluate the feasibility, implementation and efficacy of 12-week plant-based, weight-loss program that is carried out in an office setting and is open to participation to the general public via local print and online advertising or whichever methods apply. The program will include weekly education and support, and assessment of blood pressure, lipids, hemoglobin A1c, and body composition before and after starting the program. The price of the program, $645, will cover the costs of weekly education, blood pressure check, laboratory testing and body composition analysis.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLow-fat plant-based dietParticipants will follow a diet that consists of whole grains, vegetables, legumes, and fruits, with no restriction on energy intake. Animal products and added oils will be excluded. Except for light refreshments and tastings at the group sessions, no meals will be provided. Participants will handle their own food preparation and purchases, with guidance from the education team, with no restriction on energy intake.

Timeline

Start date
2019-08-30
Primary completion
2024-12-31
Completion
2025-12-31
First posted
2019-09-16
Last updated
2023-02-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04091516. Inclusion in this directory is not an endorsement.